Noche / Niche – Non-Originator Chemical Entities Products
“NOCHE (Non-Originator Chemical Entities) products refer to generic or alternative versions of originator medicines, offering affordable and accessible treatment options for patients worldwide. Within the NOCHE umbrella, three crucial categories of life-saving drugs are:
1. Biosimilars: Highly similar versions of biological originator products, replicating their safety and efficacy profiles. Examples include insulins, growth hormones, and monoclonal antibodies (mAbs).
2. Monoclonal Antibodies (mAbs): Lab-produced proteins that target specific cells or proteins, revolutionizing cancer and autoimmune disease treatments.
3. Biotherapeutics: Innovative medicines derived from living organisms or containing living organisms, addressing unmet medical needs.
In countries where these products are not manufactured locally, access to life-saving treatments is limited. This is where we come in – bridging the gap between manufacturers and distributors or government bodies, facilitating the importation of these essential drugs. Our expertise enables us to navigate complex regulatory landscapes, ensuring compliance and swift market entry.
Through our comprehensive services, we connect manufacturers with local distributors and government agencies, streamlining the import process and making these critical treatments available to patients in need. Our role as a bridge:
- Facilitates market access for NOCHE products
- Ensures regulatory compliance
- Streamlines logistics and distribution
- Fosters partnerships between manufacturers and local stakeholders
- Enhances patient access to life-saving treatments
By partnering with us, countries can overcome local manufacturing gaps, providing their citizens with vital medicines and improving healthcare outcomes. Together, we can bridge the access gap and save lives.”
